Mark Shelton
- Epidemiology top 1%
- Infectious Diseases top 1%
- Pediatrics, Perinatology and Child Health top 2%
- Hepatology top 2%
- Virology top 2%
- Co-authors
- Richard J. WhitleyDavid W. KimberlinRichard F. JacobsGene D. MorseGail J. DemmlerRobert F. PassPablo J. SánchezChin‐Yu Lin
- Topics
- HIV/AIDS drug development and treatment (32 papers)HIV Research and Treatment (16 papers)Pneumocystis jirovecii pneumonia detection and treatment (13 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Mark Shelton
60 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Epidemiology 1.8k
- Infectious Diseases 1.3k
- Pediatrics, Perinatology and Child Health 432
- Hepatology 386
- Virology 245
Countries citing papers authored by Mark Shelton
This map shows the geographic impact of Mark Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shelton more than expected).
Fields of papers citing papers by Mark Shelton
This network shows the impact of papers produced by Mark Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shelton. The network helps show where Mark Shelton may publish in the future.
Co-authorship network of co-authors of Mark Shelton
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Shelton. A scholar is included among the top collaborators of Mark Shelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Shelton. Mark Shelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 13 | |
| 4 | 32 | |
| 5 | 174 | |
| 6 | 91 | |
| 7 | 26 | |
| 8 | 85 | |
| 9 | 7 | |
| 10 | 12 | |
| 11 | 40 | |
| 12 | 51 | |
| 13 | 6 | |
| 14 | 7 | |
| 15 | 187 | |
| 16 | 16 | |
| 17 | 9 | |
| 18 | 25 | |
| 19 | 11 | |
| 20 | 34 |
About Mark Shelton
Mark Shelton is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 63 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (32 papers), HIV Research and Treatment (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (13 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Epidemiology (1.8k citations) and Virology (245 citations). Mark Shelton has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Richard J. Whitley, David W. Kimberlin, Richard F. Jacobs, Gene D. Morse, Gail J. Demmler, Robert F. Pass, Pablo J. Sánchez, Chin‐Yu Lin, Wendy Vaudry and Wayne M. Dankner. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.